ArticleOncoTargets and therapy2020

miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway.

Wu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.